Philadelphia University + Thomas Jefferson University

Scopus Results

Most Recent Peer-reviewed Publications For Department of Urology

Improvement in Therapeutic Efficacy and Reduction in Cellular Toxicity: Introduction of a Novel Anti-PSMA-Conjugated Hybrid Antiandrogen Nanoparticle

VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen

Gout of hand and wrist: the value of US as compared with DECT

Multi-institution analysis of racial disparity among African- American men eligible for prostate cancer active surveillance

The cost of prostate Ca care: What counts for AS?

Treatment of pyonephrosis with a subcutaneous ureteral bypass device in four cats

Outcome of ureteral stent placement for treatment of benign ureteral obstruction in dogs: 44 cases (2010–2013)

A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer

Creation of a Novel Digital Rectal Examination Evaluation Instrument to Teach and Assess Prostate Examination Proficiency

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study

Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017

Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical Considerations

Benign fibrous pseudotumor resulting in orchiectomy despite intraoperative frozen section

The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin

Development of the ureteroscope

Editorial Commentary

VAPC-1 Targeted64Cu-TP3805 kit preparation and its evaluation

Extensor tendinopathy of the elbow assessed with sonoelastography: histologic correlation

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study

Feasibility assessment of patient reporting of symptomatic adverse events in multicenter cancer clinical trials